GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), liraglutide, and tirzepatide (Mounjaro) have gained widespread popularity for their effectiveness in helping people lose weight and manage blood sugar levels
Data indicates that investigators using Semaglutide in the same research program as Tirzepatide or Retatrutide often do so to compare signalling breadth, tissue selectivity, or pathway overlap
The risk of this effect is highest when you first start treatment with Zepbound or after your doctor increases your Zepbound dosage
Smoking went from being perceived as sexy and sophisticated to being a deadly habit
In studies, people lost 15% to 20% of their body weight, on average
Joshua Kritzer, an associate professor of chemistry at Tufts University, says the study offers evidence that the stapled peptide approach is worth pursuing and could lead to new drugs that interfere with specific protein interactions